Attached files
file | filename |
---|---|
10-K - FORM 10-K - VIA Pharmaceuticals, Inc. | c13894e10vk.htm |
EX-31.2 - EXHIBIT 31.2 - VIA Pharmaceuticals, Inc. | c13894exv31w2.htm |
EX-31.1 - EXHIBIT 31.1 - VIA Pharmaceuticals, Inc. | c13894exv31w1.htm |
EX-32.2 - EXHIBIT 32.2 - VIA Pharmaceuticals, Inc. | c13894exv32w2.htm |
EX-21.1 - EXHIBIT 21.1 - VIA Pharmaceuticals, Inc. | c13894exv21w1.htm |
EX-10.19 - EXHIBIT 10.19 - VIA Pharmaceuticals, Inc. | c13894exv10w19.htm |
EX-10.20 - EXHIBIT 10.20 - VIA Pharmaceuticals, Inc. | c13894exv10w20.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of VIA Pharmaceuticals, Inc. (the Company) on Form 10-K
for the year ended December 31, 2010, as filed with the Securities and Exchange Commission on the
date hereof (the Report), the undersigned officer of the Company certifies, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to such
officers knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
Date: March 24, 2011
/s/ Lawrence K. Cohen | ||||
Name: | Lawrence K. Cohen | |||
Title: | President, Chief Executive Officer and Director (Principal Executive Officer) |
A signed original of this written statement required by Section 906 has been provided to the
Company and will be retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and
is not being filed as a part of this report or on a separate disclosure document.